Board of Directors
Erle T. Mast
Erle T. Mast has served as a member of our board of directors since May 2017. Mr. Mast co-founded Clovis Oncology, Inc., a public biopharmaceutical company, and served as its Executive Vice President and Chief Financial Officer from its inception in April 2009 until his retirement in March 2016. Prior to that, he served as Executive Vice President and Chief Financial Officer of Pharmion Corporation, a public biopharmaceutical company, from 2002 to 2008. Previously, Mr. Mast served as Vice President of Finance at Dura Pharmaceuticals, Inc., or Dura, a pharmaceutical company, from 1997 to 2000, and as Chief Financial Officer for the global biopharmaceuticals business of Elan Pharma International, the successor to Dura, from 2000 and 2002. From 1984 to 1997, he held roles of increasing responsibility at Deloitte & Touche LLP, serving most recently as Audit Partner. Mr. Mast is currently a member of the board of directors of Zogenix, Inc., a public pharmaceutical company, and previously served on the boards of directors and audit committees of Receptos, Inc., a public biopharmaceutical company acquired by Celgene in 2015, and Somaxon Pharmaceuticals, Inc., a public pharmaceutical company acquired by Pernix Therapeutics in 2012, as well as on the board of directors of Verus Pharmaceuticals, Inc., a pharmaceutical company. Mr. Mast received a B.Sc. in Business Administration from California State University Bakersfield.